ASCO round up: Bluebird bio’s CAR-T shines, plus blood tests for lung cancer – pharmaphorum
pharmaphorum |
ASCO round up: Bluebird bio's CAR–T shines, plus blood tests for lung cancer
pharmaphorum The results from the therapy known as bb2121 are closely watched as it has a different mechanism of action than the two already approved CAR-Ts from Gilead and Kite. Bluebird's CAR-T (chimeric antigen-receptor T–cell) therapy works by targeting B-cell … FDA chief outlines new ways to speed cancer drug approvals |
